Estrella Immunopharma, Inc.

ESLAW Stock Healthcare Biotechnology
$0.05
+0.00 (+0.00%)
Price as of Oct 14, 2026 market close

Performance

1 Month
-24.9%
3 Months
-33.2%
YTD
+5.2%
1 Year
-34.1%
3 Year annualized
-19.3%
5 Year annualized
-33.7%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
212.9%
Largest decline max drawdown, last 5 years
-96.1%
Risk-adjusted return Sharpe ratio, 1-year
0.74

Own ESLAW?

See how ESLAW contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.